ClinicalTrials.gg
Not yet recruitingNCT06909591VALLUBUpdated Jun 15, 2025

Transcultural and Psychometric Validation of the Lubben Social Network Scale in Older Adults Living in the French West Indies

An observational study in Geriatric Assessment and Patients Over 65 Years Old, sponsored by University Hospital Center of Martinique. Not yet recruiting at 1 site in Martinique. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-06-15.

Sponsored by University Hospital Center of Martinique · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
65 Years and older
Sex
All
01

Study summary

Social isolation and loneliness are common among older adults. They are associated with high morbidity and mortality, with an impact comparable to that of other known risk factors such as obesity, a sedentary lifestyle, smoking, etc.

To date, there is no tool to measure social isolation and loneliness for patients living in the French West Indies. Applying unadapted and unvalidated tools to them without taking into account local ethnocultural realities would be risky.

The investigators believe it is necessary to adapt the scales used to measure social isolation and loneliness for a population living in the French West Indies.

Through this study, the investigators propose adapting the Lubben Social Network Scale, a social isolation questionnaire, for this population and conducting its psychometric validation.

Read the detailed description

Social isolation and loneliness are common among older adults. They are associated with high morbidity and mortality, with an impact comparable to that of other known risk factors such as obesity, a sedentary lifestyle, smoking, etc.

Loneliness is a subjective concept of social relationships, most often reflecting a negative feeling.

Social isolation, on the other hand, is an objective concept of social relationships and refers to infrequent or rare contact with family and friends and can also include living alone.

The feeling of loneliness is linked to social isolation, although the association is only partial.

Indeed, some socially isolated people do not always experience loneliness; and some people living alone are not always socially isolated.

Two theories of loneliness argue that a mismatch between expectations and realities of social contact (cognitive theory) and a lack of intimate or social relationships (deficit theory) can lead to feelings of social or emotional loneliness.

A meta-analysis showed that the risk of premature death was 26% higher in people experiencing loneliness, 29% higher in those who were socially isolated, and 32% higher in the group living alone.

Another meta-analysis examined the effects of loneliness and social isolation on (among other things) mortality. The results showed that loneliness and social isolation were significantly associated with an increased risk of mortality.

The authors conclude that further research is needed to confirm whether loneliness and social isolation have a direct impact on mortality, or whether the association is indirect via the cardiovascular system and psychological health.

To date, there is no tool to measure social isolation and loneliness for patients living in the French West Indies. Applying unsuitable and unvalidated tools to them without taking into account local ethnocultural realities would be risky.

The investigators believe it is necessary to adapt the scales used to measure social isolation and loneliness for a population living in the French West Indies.

Through this study, the investigators propose adapting the Lubben Social Network Scale, a social isolation questionnaire, for this population and conducting its psychometric validation.

02

Conditions studied

  • Geriatric Assessment
  • Patients Over 65 Years Old

Keywords

  • Geriatrics
  • Lubben Social Network Scale
  • Transcultural validation
  • Psychometric validation
  • Martinique
  • French West Indies
03

In context

Lead sponsor

University Hospital Center of Martinique is the lead sponsor of 79 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged of 65 or older

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient ≥ 65 years old,
  • Hospitalized (Geriatric Day Hospital (HDJ) or Geriatric Medical Care and Rehabilitation Service (SMT)), or seen in geriatric external consultation,
  • MMS ≥ 20,
  • Patient able to understand and answer a self-administered questionnaire in French,
  • Patient having been informed of the research,
  • Patient agreeing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patient with sensory disorders preventing completion of the questionnaire,
  • Patient unable to consent to participate in the study,
  • Patient under legal protection, guardianship, or curatorship,
  • Patient who has refused to participate in the study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients aged 65 or older

    For the transcultural validation, a french version of the Lubben Social Network Scale questionnaire will be produced. For the psychometric validation, 150 patients aged of 65 or older will pass the questionnaire. The Duke Health Profile questionnaire will be also passed by the subject, for the convergent validity.

    Other: Self-assessment questionnaire

Interventions

  • OtherSelf-assessment questionnaire

    150 patients aged of 65 or older will pass the Lubben Social Network Scale questionnaire. The Duke Health Profile questionnaire will be also passed by the subject, for the convergent validity.

06

What researchers measure

Primary outcomes

  1. Transcultural validation of the Lubben Social Network Scale questionnaire

    It will be a question of obtaining a version translated into French. The translated version tested on a small group of patients (15-40) will be submitted to the author of the original version of the tool, along with a report highlighting and explaining all the modifications and difficulties noted by a group of experts.

    Time frame: 1 month

  2. Psychometric validation of the Lubben Social Network Scale questionnaire

    Questionnaire will be passed by 150 subjects. Following parameters will be measured: feasibility and acceptability, validity, reliability, and sensitivity to change.

    Time frame: 24 months

07

Study locations

1 site
  • CHU of Martinique
    Fort-de-France, 97261, Martinique
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06909591
Lead sponsor
University Hospital Center of Martinique
Responsible party
Sponsor
First posted
Apr 3, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Jun 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Jun 15, 2025

Study contacts

Nadine SIMO TABUE, MD
Contact
nadine.tabueteguo@chu-martinique.fr
05 96 48 81 95 ext. +596

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion